Director Jyoti Mehra of Lam Research Corp filed a Form 4 on November 9, 2026, disclosing the acquisition of 856 shares of common stock on November 6, 2026, at no cost.
United Airlines Holdings, Inc. officer Andrew P. Nocella filed a Form 144 notice on November 9, 2026, disclosing a proposed sale of 7,500 shares of common stock through Fidelity Brokerage Services LLC on NASDAQ.
Director Ho Kyu Kang filed a Form 4 with the SEC on November 9, 2026, disclosing the acquisition of 856 shares of Lam Research Corp common stock on November 6, 2026.
John J. Corkrean, Executive Vice President and CFO of H.B. Fuller Company, filed a Form 4 on November 9, 2026, reporting a derivative securities transaction dated November 6, 2026.
The Bank of Nova Scotia filed a free writing prospectus on November 9, 2026, disclosing terms for Market Linked Securities linked to the common stock of NVIDIA Corporation, with a stated maturity date of November 15, 2029, offered under Registration No. 333-298611.
The Goldman Sachs Group, Inc. and Goldman Sachs & Co. LLC filed a joint Schedule 13G with the SEC on October 27, 2026, disclosing beneficial ownership of Class A Ordinary Shares of Mercator Acquisition Corp. as of a September 30, 2026 triggering event.
Private Management Group, Inc. filed a Schedule 13G with the SEC on November 9, 2026, disclosing beneficial ownership of 6,315,577 shares of BrightSpire Capital, Inc. Class A Common Stock as of September 30, 2026.
The Goldman Sachs Group, Inc. and Goldman Sachs & Co. LLC filed a joint Schedule 13G with the SEC on November 6, 2026, disclosing beneficial ownership of approximately 5.1% of the common stock of Hyperliquid Strategies Inc. as of September 30, 2026.
Amanda L. Engles, Executive Vice President and CFO of CB Financial Services, Inc. (NASDAQ:CBFV), filed a Form 4 on November 9, 2026, reporting stock option exercise and share sale transactions dated November 5, 2026.
Private Management Group, Inc. filed an amended beneficial ownership statement with the SEC on November 9, 2026, disclosing a position of 3,180,007 shares of common stock in OraSure Technologies, Inc. (NASDAQ:OSUR), a diagnostics and specimen collection company headquartered in Bethlehem, Pennsylvania.